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ABSTRAK 
 
PENILAIAN STATUS IMUN DI KALANGAN PENDERMA DARAH TETAP 
LELAKI MELAYU 
 
Pendermaan darah merupakan sebahagian penting dalam sistem penjagaan kesihatan. 
Ia adalah penting untuk memastikan bekalan darah adalah mencukupi dan selamat 
dari pendermaan darah tersebut. Walau bagaimanapun, adalah penting untuk 
memastikan bahawa kesihatan penderma tidak terjejas oleh pendermaan darah atau 
komponen darah. Penderma darah utuh kehilangan kira-kira 2x10
9
 sel darah putih 
dalam satu pendermaan darah, tanpa penurunan ketara dalam kiraan limfosit darah 
periferal. Kemungkinan pendermaan darah boleh mengubah status imun perlu dinilai. 
 
Kajian ini bertujuan untuk menilai dan membandingkan tahap penanda imun antara 
penderma darah utuh kali pertama dan penderma darah utuh tetap , dan juga, untuk 
menentukan perkaitan antara tahap penanda imun dengan kekerapan pendermaan 
darah utuh. 
 
Kajian perbandingan rentas telah dilakukan di Hospital USM dari Mei 2015 hingga 
April 2016. Sampel darah peripheral diambil daripada 40 penderma darah utuh tetap 
dan 40 daripada penderma darah utuh kali pertama lelaki Melayu. Parameter 
hematologi standard termasuk jumlah sel darah putih dengan kiraan neutrofil, 
 xii 
 
limfosit, monosit, eosinofil dan basophils dengan menggunakan XE 5000 Sysmex 
hematologi analisis. Flowsitometri untuk peratusan dan kiraan mutlak CD3, CD4, 
CD8, CD16 + 56, CD19 dan nisbah CD4:CD8 menggunakan BD FACSCANTO II. 
Kuantifikasi IL-2, IL-10 dan IFNγ dengan menggunakan ELISA immunoassay. 
Kuantifikasi IgG, IgA dan IgM dengan menggunakan nephlometri. 
 
Min (SD) monosit  dalam penderma darah utuh kali pertama dan penderma darah 
utuh tetap masing-masing adalah 0.51 (0.14) dan 0.58 (0.16) dengan nilai p yang 
signifikan dalam penderma darah tetap. Min (SD) interleukin 10 dalam penderma 
darah utuh kali pertama dan penderma darah utuh tetap masing-masing adalah 6.60 
(3.05) dan 5.04 (2.28) dengan nilai p lebih rendah dalam penderma darah tetap. Min 
(SD) Ig A dalam penderma darah utuh kali pertama dan penderma darah utuh tetap 
masing-masing adalah 2.24 (0.89) dan 2.71 (1.02) dengan nilai p yang signifikan 
dalam penderma darah tetap. Parameter lain menunjukkan tiada perbezaan min yang 
signifikan. Analisis untuk menentukan perkaitan antara tahap penanda imun dengan 
kekerapan pendermaan darah utuh tidak menunjukkan hubungan yang signifikan. 
 
Kajian ini menunjukkan bahawa penderma darah tetap tiada sebarang kesan yang 
serius untuk penanda imun berbanding dengan penderma darah kali pertama. 
Perbezaan dalam kiraan mutlak monosit, IL-10 dan IgA antara kedua-dua kumpulan 
mungkin berkaitan dengan perubahan aktiviti imun tanpa ada kesan klinikal. 
Tambahan pula, tiada hubungan yang signifikan antara tahap penanda imun dengan 
kekerapan pendermaan darah tetap. Dalam batasan kajian ini, tiada risiko tambahan 
kepada penderma darah tetap akibat daripada perubahan imun.  
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 ABSTRACT 
 
EVALUATION OF IMMUNE STATUS AMONG REGULAR MALAY MALE 
WHOLE BLOOD DONORS 
 
Blood donations are an essential part of healthcare system. It is crucial to ensure that 
sufficient and safe supplies of blood from blood donation. However, it is important to 
ensure that the donor‟s health is not compromised by the donation of blood or blood 
component. Whole blood donors may lose approximately 2x10
9
 leukocytes in a 
single whole blood donation, with no significant drop in peripheral blood 
lymphocyte count. The possibility of blood donation may change the immune status 
should be assessed. 
 
This study aimed to evaluate and compare the levels of immune markers among first 
time and regular whole blood donors, as well as, to determine association between 
the levels of immune markers with the frequency of whole blood donation. 
 
A comparative cross sectional study was done at Hospital USM from May 2015 to 
April 2016. Peripheral blood was taken from 40 regular and 40 first time; Malay 
male whole blood donors. The immune marker parameters that were studied included 
TWBCs with neutrophils, lymphocytes, monocytes, eosinophils and basophils count 
by using XE 5000 Sysmex haematology analyzer (Koba, Japan).  Flow cytometry for 
percentage and absolute count of CD3, CD4, CD8, CD16+56+, CD19 and CD4:CD8 
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ratio using BD FACSCANTO II.  IL-2, IL-10 and IFNγ level quantification by using 
ELISA immunoassay. IgG, IgA and IgM level quantification by using nephlometry. 
 
The mean (SD) of monocytes absolute count in first time and regular whole blood 
donors were 0.51 (0.14) and 0.58 (0.16), respectively with p value significantly 
higher in regular whole blood donors. The mean (SD) of interleukin 10 in first 
time and regular whole blood donors were 6.60 (3.05) and 5.04 (2.28), 
respectively with p value significantly lower in regular whole blood donors.  The 
mean (SD) of Ig A in first time and regular whole blood donors were 2.24 (0.89) 
and 2.71(1.02), respectively with mean value significantly higher in regular whole 
blood donors. Other parameters showed no significant mean different. Analysis 
for determination of association between the levels of immune markers with 
frequency of whole blood donation showed no significant association. 
 
This present study demonstrates regular blood donors showed no serious significant 
effects both for cellular and humoral immune markers when compared with the first 
time blood donors. The differences in monocytes absolute count, IL-10 and IgA 
between the two groups are probably related to variation of immune activity with no 
clinical significance.  Furthermore, there was no significant association between the 
levels of immune markers with frequency of whole blood donation.  Within 
limitations of this present study, there are no added risks to regular blood donors as a 
result of immune changes. 
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INTRODUCTION 
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1.0  INTRODUCTION 
  
Blood donations are an essential part of our healthcare system. If we did not 
have volunteers to donate blood, many medical procedures could not take place. 
Doctors and surgeons require blood and blood component products to carry out life-
saving and life-enhancing treatments every day throughout the years. It is crucial to 
ensure that sufficient and safe supplies of blood from blood donation are available at 
all times, since there are no substitutes for human blood. Besides, it is important to 
ensure that the donor‟s health is not compromised by the donation of blood or blood 
components. Thus, it is important to practice safe blood donation to prevent 
complication. 
 
Blood donation process has to follow strict guidelines to ensure that the donation 
does not cause any harm to the donors. Generally, the minimum interval for each 
whole blood donation is 8 weeks in practice and not more than 4 times a year. 
Healthy donors with the weight of 50 kg or more could donate blood approximately 
450 to 500 ml per each donation. Each donation wills loss approximately 250 ml 
RBC and 250 ml plasma. 
 
Whole blood donors also may lose approximately 2x10
9
 leukocytes in a single whole 
blood donation, with no significant drop in peripheral blood lymphocyte count 
(Strauss et al., 1994).  No known immediate adverse effects are associated with the 
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slight decreases in peripheral blood lymphocyte counts following whole blood 
donation. The possible long term effect due to repeated loss of blood and blood 
component from whole blood donation was also not clear. 
 
Few studies have been published addressing long term alteration in the immune 
system as an effect of chronic blood donation.  Even though, there are no clinically 
relevant health effects attributable to multiple blood donations have been 
demonstrated, a few studies have revealed immunologic changes in long term whole 
blood donation. A decrease in total peripheral blood lymphocyte counts and 
significant decrease in natural killer (NK) cell activity in blood donors, with the 
lowest values observed in active long term blood donors was demonstrated by Lasek 
et al. (Lasek et al., 1987). A decrease cytotoxic potential of NK cells in regular 
whole blood donors was also demonstrated by Olinescu et al. (Olinescu et al., 1988). 
 
Lewis at al. demonstrated increased expression of CR3 receptors on both monocytes 
and neutrophils from the whole blood donors as compared to those from non-donor 
controls (Lewis et al., 1992). These results are consistent with findings reported by 
Morse et al previously, who found that complement activation occurs during blood 
donation. They also demonstrate that neutrophils showed an increased expression of 
C3b (CR1) receptor after donation as compared to before donation (Morse et al., 
1988). 
In general, published data on the effects of long term whole blood donation on the 
immunologic status of individual donors remains paucity. Furthermore, 
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understanding of the possible clinical significance of immune activation and changes 
in relation to long term whole blood donation is important to avoid compromised 
donor wellbeing, as well as, to demonstrate immune responses which benefit the 
individual regular donors. Thus, can improve pre-donation counseling, and hence 
promote blood donation programme. 
 
Therefore, the purpose of this study was to investigate lymphocytes subsets and 
mediators that are important in host defense in long term regular whole blood donors. 
By using flow cytometry in conjunction with various immunoassays, this study 
characterized peripheral blood lymphocytes and cytokines as well as 
immunoglobulin from regular whole blood donors and compared these findings to 
data obtained from first time whole blood donors (control). 
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2.0 LITERATURE REVIEW 
 
2.1 Introduction 
 
In blood banking, there is accepted policy to make blood donation as convenient and 
safe as possible for all donors. The blood from regular blood donors frequently 
condemned on the claimed that the donors suffer from a poor nutritional status, 
hence that it is a poor source of blood component due to frequently repeated blood 
donations. A study by Jacobs et al revealed a high number of misconceptions about 
blood donation and fear that blood donation could damage the donor‟s health in 
Mwanza region, Tanzania (Jacobs and Berege, 1995). 
 
In this recent years, it has become apparent that malnutrition can result in multiple 
defects in the immune system, which involving humoral responses, cell-mediated 
responses, phagocytosis and the complement system. Therefore, blood donors are 
encouraged to donate their blood only after careful assessment and clinical 
examination of the general condition. 
 
Few study have been published addressing long term effect in the immune system as 
a regular blood donation with few studies revealed immunologic changes in regular 
whole blood donation. A decreased in total peripheral blood lymphocytes count and 
significant decreased in Natural Killer (NK) cell activity in blood donors with the 
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lowest level observed in active long term blood donors was demonstrated by Lasek et 
al. (Lasek et al., 1987).   
 
 Previous study by Karger et al. shown that patient undergoing pre-operative 
autologous blood donation prior to elective hip arthroplasty surgery experience 
significant enduring immunological changes following donation (Karger et al., 
2007). The total number of leukocytes remains constant, the number of granulocytes 
increases at the expense of fall in lymphocytes. 
 
Another study by Lewis SL and Bonner PN demonstrated many plasma donors have 
low levels of serum protein, globulin and IgG (Lewis SL & Bonner PN, 1994). 
However, plasmapheresis procedure is different from whole blood donations. Plasma 
donors may donate larger volumes of plasma and may donate two times per weeks 
(American Red Cross) and depending on their body weight, which may donate up to 
1800 ml of plasma per week.  
 
Only little data is available on the long term effect of whole blood donations 
particularly on the immune system alteration. The existing data more focus on 
regular plasmapheresis in which the procedure allows the donors to donate plasma 
every two weeks interval. 
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Therefore, the aim of this study was to investigate whether long-term and regular 
blood donations will alter some aspect of the immune markers of the blood donors. 
We also studied the possibility of association of regular whole blood donors with 
humoral and cellular immune markers. 
 
2.2 Blood donation 
 
2.2.1 Introduction 
 
Blood can be defined as the fluid that circulates in the principle vascular system of 
human beings and others vertebrates, consisting of plasma in which the red blood 
cells, white blood cells, and platelets are suspended. Blood carries oxygen and 
nutrient from the lungs to body cells. Blood also carries proteins and platelets that let 
blood to clot whenever there has been an injury. It also carries waste to be eliminated 
from the body. Adult may have 4-6 liters blood in their body.  
 
Blood donation occurs whenever a person voluntarily as blood withdrawn and used 
for transfusion. When someone donates whole blood, only one unit (350-450 mls) 
will be withdrawn; healthy donors are allowed to donate 10 per cent of their blood 
volume.  One unit can help to save or improve the lives of up to three people. In fact, 
some donors can help more than 500 people, over a life time. Men can only donate 
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whole blood four times a year, and women three times a year (due to iron level) as 
red blood cells takes several weeks to be restored. 
 
One unit of RBCs transfused to an adult recipient should increase the hemoglobin 
concentration by 1g/dL (Klein et al., 2007). 
 
2.2.2 Types of blood donation 
 
Blood donation can be divided into two types namely as whole blood donation and 
apheresis donation. Whole blood donation implies the whole blood is collected from 
the donors whereas in apheresis donation, only selected blood component is 
collected. Whole blood constitutes of red blood cells (RBCs), white blood cells 
(WBCs), platelet, plasma and few other components. It becomes the main source for 
the preparation of other blood components where the separation involves manual 
processing procedure under controlled temperature with specific centrifugation speed 
following the specific component processing guidelines. 
 
On the other hand, the word “apheresis” is initially originated from the words 
“aphairesis”, a Greek word, which signify “to separate”, “to take away by force”, or 
“to remove”. The process started with the withdrawal of whole blood from a donor, 
extraction of the desired component into a collecting blood bags through a filter 
membrane or by centrifugation methods and returning the other unused blood 
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component back into the donor. Apheresis likewise can be used as a therapeutic 
method in some of the medical cases, act by removing specific pathologic 
components or substance from a patient‟s blood for therapeutic purpose (Winters, 
2012). 
 
2.2.3 Whole blood donation  
 
Whole blood donation is the most common type of blood donation. Blood contains 
erythrocytes (RBC), leukocytes (WBC) and platelet suspended in plasma. Whole 
blood is the most common starting product for component preparation which targets 
a specific patient‟s need as well as enabling each component to be stored optimally.  
 
The component therapy is more appropriate to target a patient‟s specific indication 
for transfusion; for example RBC products for symptomatic anaemia, plasma 
products for multiple coagulation factor deficiencies, cryoprecipitate for replacement 
of fibrinogen and platelet products for thrombocytopenia or platelet dysfunction. 
  
Generally, 450 ml of whole blood is collected into a blood bag with 70 ml of 
anticoagulant-preservative solution, creating a product with a final haematocrit of 
38%. Whole blood is stored at 1-6 °C. 
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2.2.4 Blood donors 
 
Blood donation is one of the most significant contributions that a person can make 
towards their society. It is not harmful for an adult person to donate their blood. 
Hence, within few days to weeks, body of the blood donors will regenerate their 
blood.        
The selection of appropriate blood donors is important to protect their health during 
and following donation, as well as to avoid any undesirable health impact. Key 
elements of the selection process, as part of the overall approach to blood and donor 
safety are the donor health history questionnaire, physical examination and infectious 
disease screening. The screening process includes direct questioning about specific 
risk behaviors, medications, travel, and other factors that potentially effect recipient 
or donor safety (AABB, 2014). 
 
Blood donor should be between 18-55 years of age with a weight more than 45 kg or 
above with normal blood pressure, pulse rate, temperature and healthy. Both men and 
women can donate their blood. There are few conditions in which donors are 
permanently deferred for donating their blood. The donors with history of epilepsy, 
psychotic disorders, abnormal bleeding tendencies, malignancy should be 
permanently deferred for blood donation. 
 
Potential donors will be evaluated for anything that may cause their blood unsafe to 
be used by others who in needs. The screening includes testing for transmitted 
 12 
 
diseases by blood transfusion, including HIV, viral Hepatitis B, Hepatitis C and 
syphilis. The donor will be instructed to answer questions regarding medical history 
and take a short physical examination to make sure the donation is not hazardous to 
his or her health. 
 
The donor‟s haematocrit or haemoglobin level is tested to make sure that the loss of 
blood will not cause them to be anaemic. Pulse, blood pressure and body temperature 
are evaluated. Eventually, eligible donor will be asked to give his or her consent. 
 
2.2.5 Donor selection and donor deferral 
 
Blood and blood component is one of the important treatment modalities and 
constantly in demand as they are utilized in various medical procedures. Thus, it is 
very crucial to ensure that the blood is safe for usage and come from the safe donors. 
In most of the countries in the world including Malaysia, blood supply is contributed 
by voluntary, non-remunerated blood donors. For that safety purpose for blood being 
donated as well as donor health did not compromised, blood donor criteria selection 
is created to screen and to ensure the individuals who fulfilled the criteria will be 
only accepted to donate blood (Eder et al., 2009).  
 
Deferral of the donors who are not fulfilled the selection criteria can happen at any 
stage of blood donation began from registration, during pre-donation interview, 
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during the blood donation or even after the blood donation. This precautionary 
measure was taken in order to protect both of the blood donors as well as patients 
whom received the transfusion. Pre-donation counseling particularly is conducted to 
assess donor eligibility, complemented by various blood unit testing which will be 
done later, contribute to the safety of the unit (Sandborg and Thornton, 1994). 
 
Pre-donation interview alone considered as one of the essential preliminary measure 
to capture the likelihood of the window period for certain communicable diseases, 
automatically reducing the risk of disease transmission, particularly in case that 
being undetected by standard blood serology test (Germain & Goldman, 2002). 
 
A person who does not meet the blood donor selection criteria (e.g low haemoglobin, 
low blood pressure) may experience adverse donor reaction such as headache, 
giddiness or fainting episode. They will be temporarily deferred with appropriate 
advised and encourage to return for blood donation after the temporary deferral 
period (Halperin et al., 1998). 
 
On the other hand, blood donor will be permanently excluded from blood donation 
due to medical condition or due to their high risk behavior and lifestyle (high risk 
group).  Donors with medical conditions such as malignancy, bleeding abnormality 
as well as heart disease are prohibited from blood donation as this process will 
potentially affect their well-being, thus permanent deferral is indicated. High risk 
group (e.g. individuals with multiple sex partners, sex workers, and intravenous drug 
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users) will be permanently deferred in perspective of risk of transmitting transfusion 
transmitted disease (Lim et al, 1993). 
 
Individual who do not eligible for blood donation will be deferred either temporarily 
or permanently relying upon the reason for deferral. A temporary deferral can be as 
short as twenty four hours to as long as two years, whereas permanent deferral refers 
to a blood donor who disqualified from blood donation indefinitely. The commonly 
reported cause for temporary deferral are low pre-donation haemoglobin level, low 
or high blood pressure, underweight, taking medications (e.g. antibiotics), medical 
conditions (e.g. upper respiratory tract infection), minor or major surgical procedure 
(e.g. acupuncture, tattoo, dental procedure) (Germain and Goldman, 2002). 
 
The donor deferral rates may vary from a blood donation centre to another, estimated 
around 5% to 25%. In Malaysia, it is estimated around 15% to 20% of blood donors 
are reported to be deferred from blood donation in Pusat Darah Negara as well as 
throughout the countries every year. A large portion of them are temporarily 
deferred, and the top three listed for this deferral are contributed by low haemoglobin 
(Hb) level, followed by high or low blood pressure. About 10% of donor deferrals 
are permanent deferral in which majority of them are due to high risk behavior 
(Seong, 2013). 
 
A retrospective study done among Turkish population according to the gender, age 
and education level, in 5 years beginning from 2001 until 2006 likewise 
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demonstrated quite similar findings in term of cause of donor deferral;  low Hb 
(20.7%), medical condition such as upper respiratory tract infection (17.7%), 
hypertension (5.6%), polycythaemia (5.6%) with addition of high risk sex partner 
(16.7%). These are the top five listed in the entire group. The main deferral cause in 
male donor is upper respiratory tract infection, while in female donors is due to low 
level of haemoglobin. Interestingly, the education level of donors demonstrated no 
impact on the rate of deferral for both genders at different age group (Arslan, 2007).  
 
Furthermore, studies conducted in Hospital Universiti Sains Malaysia, Kubang 
Kerian (HUSM) demonstrated approximately 5.6% blood donors are deferred in this 
blood centre in year 2006. Majority of the donors (64.1%) are regular donors. This 
study also reported similar findings for the cause of deferral as Pusat Darah Negara, 
caused by low haemoglobin level (40.7%) with female donors dominating (69%) in 
this category. The second common cause are high blood pressure (29.4%), 
dominated by male donor which constitute approximately 45%. The other causes 
include medical illness (15.6%), low blood pressure (3.5%), short interval between 
donation (1.7%), polycythaemia (1.7%) and other causes of deferral (5.2%) (Rabeya 
et al, 2008). 
 
Permanent deferral could affect a donor psychologically, so that the purpose of donor 
deferral must be clearly explained considering it is the best manner for both blood 
donor and blood recipient. Understanding this will make it easier for a blood donor to 
accept the deferral, either temporary or permanent. Permanently deferred donors will 
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be counseled appropriately and professionally by trained staff so that the reason of 
being permanently deferred can be accepted by the donor (Lim, 1993).  
 
Blood donor selection criteria are also regularly reviewed to improve the selection 
criteria and to prevent unnecessary donor deferral. Clearly, this selection guidelines 
help to avoid or reducing harm to the blood donors, recognize any probable 
significant pathology in the donors, maximizing the therapeutic quality of the blood 
and blood product as well as to prevent any harm to the recipient (Arslan, 2007). 
 
 2.2.6 Benefit of giving blood  
 
Blood donors have a satisfaction and joy of saving human lives. Meanwhile, few 
studies on regular blood donation may reduce the risk of cardiovascular disease 
(Haidari et al., 2001; Kiechl et al., 1997; De Valk et al., 1999).  
 
One study conducted by Meyers et al., demonstrates  blood donation in nonsmoking 
men was associated with reduced risk of cardiovascular event (Meyers et al., 1997). 
Another study conducted by Salonen et al., suggested that frequent blood loss 
through voluntary blood donations may be associated with a reduced risk of acute 
myocardial infarction in middle-age men (Salonen et al., 1998).  
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Tuomainen et al., demonstrated reduced risk of coronary events in male blood donors 
(Tuomainen et al., 1997). However, study done by Alberto et al., revealed there was 
no significant associations were found between blood donation and the risk of 
myocardial infarction in analyses restricted to men with hypercholesterolemia or 
those who never used antioxidant supplements or aspirin (Ascherio et al., 2001). 
 
Another few studies suggested reduced risk of cancer occurrence with regular blood 
donations (Edgren et al., 2007: Merk et al, 1990; Lasek et al 1994). A study by Merk 
et al. reported there was significant decreased cancer incidence among blood donors 
(Merk et al., 1990). However, in another study conducted by Edgren et al. 
demonstrated repeated blood donation was not associated with increased or 
decreased risk of cancer (Edgren et al., 2008). 
 
Presence of healthy donor effect while comparing donors with the general population 
and active versus lapsed donors was demonstrated by Atsma Et al. (Atsma et al., 
2011). Furthermore, all regular blood donors may enjoy free health checkup yearly. 
 
2.3 Immune system 
2.3.1 Introduction 
 
The immune system is an important host defense system that protects body from 
various infection and disease. To function normally, immune system should be able 
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to detect variety of pathogen, such bacteria, virus, parasitic worm infection as well as 
able to distinguish them from own healthy tissue.  
 
Immune system can be classified into subsystem of innate immune system versus 
adaptive/acquired immune system, and humoral immunity versus cell-mediated 
immunity. Adaptive/acquired immune system confers immunological memory after 
an initial response to a specific pathogen, leading to an augment response to 
subsequent encounters with the same pathogen. 
 
The immune system defends body from infection with layered defenses of increasing 
specificity. Initially physical barrier for example skin and mucous membrane prevent 
invasion of pathogens such as bacteria and viruses from entering the body. However, 
if a pathogen breaches these barriers, the innate immune system provides an 
immediate, but not specific response. If pathogen successfully overcomes the innate 
response, the adaptive immune system will be activated by innate response.  
 
This advance response is then retained after the pathogen has been abolished, in the 
form of an immunological memory, and allows the adaptive immune system to 
mount faster and stronger attack each time this similar pathogen is encountered. 
 
The induction of a proper effector function in clonal cells is intervened by the innate 
immune system, while both the adaptive and innate immune responses control 
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self/non self-discrimination. The innate, nonclonal system controls the initiation of 
the adaptive immune response by regulating the expression of co stimulatory activity 
on antigen presenting cells (APCs), and instructs the adaptive immune system to 
build up a particular effector response by releasing effector cytokines. 
 
The functioning of lymphocytes bearing clonally-rearranged receptors is absolutely 
subject to these signals that are provided by the innate recognition system. Therefore, 
we consider the innate and adaptive immune responses to be integrated as a single 
immune system, with the innate response preceding, and being necessary for, the 
adaptive immune response (Medzhitov and Janeway, 1997). 
 
2.3.2 Innate immune system 
 
The innate immune system, otherwise called the non-specific immune system 
(Young and Criscitiello, 2011), is an important subsystem of the overall immune 
system that comprises the cells and mechanisms that defend the host from infection 
by various organisms.  
 
The innate immune response is the first line of defense against infectious and 
noxious challenges. It is activated rapidly and usually involves cells at cutaneous and 
mucosal surfaces. These cells use germ-line encoded pattern recognition receptors to 
detect the presence of microbial molecules or products of tissue damage, and mount 
a stereotypic response that includes the activation of anti-microbial mechanisms and 
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the emission of chemotactic molecules that recruit other cells of the immune system 
to the site of infection or damage (Kawai & Akira, 2010). 
 
The cells of the innate system recognize and react to pathogens in a generic way, but, 
unlike the adaptive immune system, the system does not confer long-lasting or 
protective immunity to the host (Gary M Wessel, 2004).   
 
The innate immune system is made out of a network of cells including neutrophils, 
NK cells, monocytes/macrophages, and dendritic cells that mediate the earliest 
interactions with pathogens. Innate immune systems confer immediate defense 
against infection. 
 
Neutrophils constitute the primary immune defense against rapidly dividing bacteria, 
yeast and fungal infections, initiate microbicidal mechanisms including generation of 
reactive oxygen and nitrogen species, release of proteolytic enzymes, and 
microbicidal peptides from cytoplasmic granules. 
 
NK cells mediate MHC-independent cytotoxicity in the innate immune defense 
against viral infections and a few malignancies. Absolute numbers of NK cells 
increase with age, reflecting an increase in CD56 dim cells, but NK cell cytotoxicity 
on a per cell basis is diminished and levels of cytokines and chemokines such as 
RANTES, MIP1a, and IL-8 produced upon NK cell activation are also reduced 
(Mocchegiani et al., 2009). 
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Furthermore, in response to infection, the innate immune system will strengthens 
iron-withholding defenses, ensuring that the host-pathogen interface remains an ever 
evolving battleground for precious metal (Cassat et al., 2013). 
 
2.3.3 Adaptive immune system 
          
The adaptive immune system, otherwise called as the acquired immune system or, 
more rarely, as the specific immune system, is a subsystem of the overall immune 
system that is consist of highly specialized, systemic cells and processes that 
eliminate or prevent pathogen growth. 
 
Adaptive immunity creates immunological memory after an initial response to a 
specific pathogen, and prompts an enhanced response to subsequent encounters with 
that pathogen. Like the innate system, the adaptive system incorporates both humoral 
immunity components and cell-mediated immunity components. 
 
Unlike the innate immune system, the adaptive immune system is highly specific to a 
particular pathogen. Adaptive immunity can likewise provide durable protection. The 
cells that carry out the adaptive immune response are white blood cells known as 
lymphocytes.  
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Adaptive immunity develops through the course of days to weeks taking after 
exposure to foreign substances and relies on the activation, proliferation and 
differentiation of antigen specific B and T lymphocytes, which are involved in 
antibody- and cell-mediated responses, respectively (Bonilla & Oettgen, 2010). 
 
Two important broad classes - antibody responses and cell mediated immune 
response are also carried by two different lymphocytes (B cells and T cells). In 
antibody responses, B cells are stimulated to secrete antibodies, which are proteins 
also known as immunoglobulins. 
 
 B cells and T cells are derived from the same multipotent haematopoietic stem cells, 
and are morphologically indistinguishable from each other until after they are 
activated. B cells play a large role in the humoral immune response, while T cells are 
involved in cell-mediated immune responses. 
 
All cells are capable of presenting antigen through the function of major 
histocompatibility complex (MHC) molecules with the exception of erythrocytes 
(non-nucleated cells) (Chakrapany, 2013). 
 
Several T cell subgroups can be stimulated by professional APCs, and each type of T 
cell is specially equipped to deal with each unique toxin or bacterial and viral 
pathogen. The sort of T cell stimulated, and the type of response generated, depends 
to some extent, on the context in which the APC first encountered the antigen. 
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2.4. Immune subset and immune marker 
 
2.4.1.  T cells 
 
T helper cells are a type of T cells which play an important role in the immune 
system, particularly in adaptive immune system. They assist the activity of the other 
immune cells by releasing T cell cytokines. They are important in B cell antibody 
class switching, in the activation and growth of cytotoxic T cells, and maximizing 
bactericidal activity of phagocytes, for example macrophages. Mature T helper cells 
express the surface protein CD4 and considered as CD4+ T cells which play an 
important role in immune system. Helper T cells are capable of influencing a variety 
of immune cells, and the T cell response generated including extracellular signal like 
cytokines. Proliferating helper T cells change into effector T cells differentiate into 
two major subtypes, which known as T helper 1 and T helper 2.  
 
T helper 1 (Th1)/Th2 cell balance of the patients since a Th1-type cytokine reaction 
pattern is should be an important defence mechanism of the adaptive cellular 
immune response against intracellular infectious agents, whereas a Th2-type 
cytokine secretion pattern regulates B-cell proliferation and antibody class switching, 
along these lines instructing humoral immune responses (Mosmann&Sad, 1996; 
Dong&Flavell, 2001; Roitt & Delves, 2004). 
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A study by Malaguinera showed there was major changes in the immune system 
associated with aging in primary lymphoid organs as well as a description of 
molecular mechanisms, and the impact on cancer development (Malaguarnera L, 
2010).  
 
2.4.2 NK cell 
 
Natural killer (NK) cells were found over 30 years back. NK cells are large granular 
lymphocytes that belong to the innate immune system because unlike T or B 
lymphocytes of the adaptive or antigen-specific immune system, NK cells don't 
rearrange T-cell receptor or immunoglobulin genes from their germ line 
configuration.  
 
Thus far it has been fully appreciated that NK cells can secrete cytokines and 
chemokines that impact the host's immune response, and/or kill certain infected or 
transformed cells via perforin/granzyme (Orange, 2006).  
 
Interferon gamma (IFN-γ) is considered the prototypic NK-cell cytokine, and its 
production by NK cells is known to initiate the Th1 immune response (Mocikat et 
al., 2003), induce APCs to further up-regulate MHC class I expression (Wallach et 
al., 1982), activate macrophage killing of obligate intracellular pathogens (Filipe-
